Linezolid to Treat Extensively-Drug Resistant Tuberculosis
Condition(s):Pulmonary Tuberculosis; Multidrug Resistant Tuberculosis; Extensively Drug Resistant TuberculosisLast Updated:March 14, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary Tuberculosis; Multidrug Resistant Tuberculosis; Extensively Drug Resistant TuberculosisLast Updated:March 14, 2016Completed
Condition(s):Multi-Drug Resistant Tuberculosis; Extensively Drug Resistant TuberculosisLast Updated:August 17, 2012Completed
Condition(s):Pneumonia; Blood Stream InfectionLast Updated:November 14, 2022Completed
Condition(s):Colistin; Rifampin; Acinetobacter InfectionsLast Updated:August 9, 2018Completed
Condition(s):Ventilator Associated Pneumonia; Antibiotic Resistant InfectionLast Updated:April 20, 2020Unknown status
Condition(s):Multidrug-resistant Tuberculosis; Extensively Drug-resistant TuberculosisLast Updated:July 1, 2013Completed
Condition(s):PneumoniaLast Updated:February 11, 2014Unknown status
Condition(s):TuberculosisLast Updated:November 27, 2017Approved for marketing
Condition(s):Latent TuberculosisLast Updated:June 7, 2016Completed
Condition(s):Hospital InfectionLast Updated:September 1, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.